Bridgefront Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,349
Closed -$1.56M 628
2025
Q4
$1.56M Buy
+3,349
New +$1.55M 0.39% 61
2024
Q2
Sell
-1,388
Closed -$463K 565
2024
Q1
$463K Buy
+1,388
New +$424K 0.35% 84
2022
Q4
Sell
-1,193
Closed -$219K 427
2022
Q3
$219K Buy
+1,193
New +$238K 0.22% 207
2021
Q4
Sell
-2,105
Closed -$511K 370
2021
Q3
$511K Sell
2,105
-784
-27% -$192K 0.53% 33
2021
Q2
$597K Sell
2,889
-3,818
-57% -$778K 0.23% 134
2021
Q1
$1.26M Buy
6,707
+836
+14% +$147K 0.39% 32
2020
Q4
$966K Buy
+5,871
New +$858K 0.33% 58

Other funds holding HCA

Bridgefront Capital's HCA Position: Q1 2026 in Review

Bridgefront Capital sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 3,349 shares — an estimated $1.56M sold.

Bridgefront Capital first reported a position in HCA in Q4 2020 and held it in 7 quarters. The position peaked at $1.56M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Bridgefront Capital reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 3,349 HCA Healthcare shares in Q1 2026, an estimated $1.56M.
  • Bridgefront Capital first reported a position in HCA Healthcare in Q4 2020 and held it in 7 quarters.
  • Bridgefront Capital's HCA Healthcare position peaked at $1.56M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.